DE69806750D1 - Amidinderivate als inhibitoren von no-synthase - Google Patents

Amidinderivate als inhibitoren von no-synthase

Info

Publication number
DE69806750D1
DE69806750D1 DE69806750T DE69806750T DE69806750D1 DE 69806750 D1 DE69806750 D1 DE 69806750D1 DE 69806750 T DE69806750 T DE 69806750T DE 69806750 T DE69806750 T DE 69806750T DE 69806750 D1 DE69806750 D1 DE 69806750D1
Authority
DE
Germany
Prior art keywords
synthase inhibitors
amidine derivatives
amidine
derivatives
synthase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69806750T
Other languages
English (en)
Other versions
DE69806750T2 (de
Inventor
James Macdonald
James Matz
William Shakespeare
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of DE69806750D1 publication Critical patent/DE69806750D1/de
Application granted granted Critical
Publication of DE69806750T2 publication Critical patent/DE69806750T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69806750T 1997-05-05 1998-04-28 Amidinderivate als inhibitoren von no-synthase Expired - Fee Related DE69806750T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9701681A SE9701681D0 (sv) 1997-05-05 1997-05-05 New compounds
PCT/SE1998/000785 WO1998050382A1 (en) 1997-05-05 1998-04-28 Amidine derivatives as inhibitors of nitric oxide synthase

Publications (2)

Publication Number Publication Date
DE69806750D1 true DE69806750D1 (de) 2002-08-29
DE69806750T2 DE69806750T2 (de) 2003-03-06

Family

ID=20406835

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69806750T Expired - Fee Related DE69806750T2 (de) 1997-05-05 1998-04-28 Amidinderivate als inhibitoren von no-synthase

Country Status (25)

Country Link
US (1) US6489322B1 (de)
EP (1) EP0983268B1 (de)
JP (1) JP2001523262A (de)
KR (1) KR20010012228A (de)
CN (1) CN1255131A (de)
AR (1) AR012601A1 (de)
AT (1) ATE221065T1 (de)
AU (1) AU734391B2 (de)
BR (1) BR9809218A (de)
CA (1) CA2288333A1 (de)
DE (1) DE69806750T2 (de)
EE (1) EE9900474A (de)
HU (1) HUP0001873A3 (de)
ID (1) ID22885A (de)
IL (1) IL132678A0 (de)
IS (1) IS5236A (de)
MX (1) MXPA99009882A (de)
NO (1) NO995403L (de)
NZ (1) NZ500675A (de)
PL (1) PL336853A1 (de)
SE (1) SE9701681D0 (de)
SK (1) SK140599A3 (de)
TR (1) TR199902720T2 (de)
WO (1) WO1998050382A1 (de)
ZA (1) ZA983736B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI243164B (en) * 2001-02-13 2005-11-11 Aventis Pharma Gmbh Acylated indanyl amines and their use as pharmaceuticals
US20030045449A1 (en) * 2001-08-15 2003-03-06 Pfizer, Inc. Pharmaceutical combinations for the treatment of neurodegenerative diseases
US8896004B2 (en) * 2005-04-26 2014-11-25 Kabushiki Kaisha Toshiba White LED, backlight using the same, and liquid crystal display device
US20100105657A1 (en) * 2005-07-05 2010-04-29 Astrazeneca Ab Compounds, Process for their Preparation, Intermediates, Pharmaceutical Compositions and their use in the Treatment of 5-HT6 Mediated Disorders such as Alzheimer's Disease, Cognitive Disorders, Cognitive Impairment Associated with Schizophrenia, Obesity and Parkinson's Disease
MY148644A (en) 2005-07-18 2013-05-15 Orion Corp New pharmaceutical compounds
WO2008053446A2 (en) * 2006-11-02 2008-05-08 Piramal Life Sciences Limited Benzoxazepine compounds, their preparation and use
WO2008108445A1 (ja) 2007-03-07 2008-09-12 Takeda Pharmaceutical Company Limited ベンゾオキサゼピン誘導体およびその用途
WO2008144483A2 (en) * 2007-05-18 2008-11-27 Armgo Pharma, Inc. Agents for treating disorders involving modulation of ryanodine receptors
CA2763099A1 (en) * 2009-05-22 2010-11-25 Exelixis, Inc. Benzoxazepines based p13k/mt0r inhibitors against proliferative diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09504278A (ja) 1944-06-01 1997-04-28 ザ、ウェルカム、ファンデーション、リミテッド Noシンターゼインヒビターとしての置換尿素およびイソチオ尿素誘導体
RU2130017C1 (ru) 1993-08-12 1999-05-10 Астра Актиенболаг Производные амидина, способ их получения и лекарственное средство на их основе, обладающее свойством ингибировать активность синтетазы оксида азота (у)
JPH09504028A (ja) 1993-10-21 1997-04-22 ジー.ディー.サール アンド カンパニー 酸化窒素シンターゼ抑制剤として有用なアミジノ誘導体
WO1996001817A1 (en) * 1994-05-07 1996-01-25 Astra Aktiebolag Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase
TW397812B (en) * 1995-02-11 2000-07-11 Astra Ab Bicyclic isothiourea derivatives useful in therapy
BR9509297A (pt) * 1995-08-10 1998-07-07 Astra Ab Composto composição farmacêutica utilização de um composto e processos de tratamento ou prolifaxia de uma doença ou condição na qual a síntese ou suprasintese da sintetase de óxido nitrico forma uma parte contribuinte e desordens neurodegenerativas ou de enxaqueca ou de prevenção e reversão da tolerância a opiatos e diazepinas ou de tratamento do vicio em tóxicos e de preparação de um composto
TW458978B (en) * 1995-11-07 2001-10-11 Astra Ab Amidine and isothiourea derivatives as inhibitors of nitric oxide synthase

Also Published As

Publication number Publication date
NO995403L (no) 2000-01-05
IS5236A (is) 1999-11-01
CN1255131A (zh) 2000-05-31
HUP0001873A2 (hu) 2001-01-29
ZA983736B (en) 1998-11-05
SE9701681D0 (sv) 1997-05-05
JP2001523262A (ja) 2001-11-20
MXPA99009882A (es) 2005-11-22
AU734391B2 (en) 2001-06-14
ATE221065T1 (de) 2002-08-15
US6489322B1 (en) 2002-12-03
DE69806750T2 (de) 2003-03-06
EP0983268B1 (de) 2002-07-24
AU7459898A (en) 1998-11-27
NZ500675A (en) 2001-05-25
WO1998050382A1 (en) 1998-11-12
KR20010012228A (ko) 2001-02-15
EE9900474A (et) 2000-06-15
NO995403D0 (no) 1999-11-04
TR199902720T2 (xx) 2000-02-21
HUP0001873A3 (en) 2001-12-28
AR012601A1 (es) 2000-11-08
PL336853A1 (en) 2000-07-17
EP0983268A1 (de) 2000-03-08
BR9809218A (pt) 2000-06-27
ID22885A (id) 1999-12-16
CA2288333A1 (en) 1998-11-12
SK140599A3 (en) 2000-06-12
IL132678A0 (en) 2001-03-19

Similar Documents

Publication Publication Date Title
EE200000031A (et) Uued spiroasabitsüklilised heterotsüklilised ühendid
DE69725465D1 (de) 6-phenylpyridyl-2-amin-derivate verwendbar als nos-inhibitoren
DE69531558D1 (de) Heterocyclische kondensierte pyrimidin-derivate
ATE245142T1 (de) No-synthase inhibitoren
ATE260243T1 (de) N-aroylphenylalaninderivate
ATE235220T1 (de) Resorcinderivate
ID22781A (id) Turunan-turunan nikotinamida
DE69824199D1 (de) Lactamverbindungen als metalloprotease-inhibitoren
DE59809235D1 (de) Platten- oder leistenförmige Bauteile
PT1049695E (pt) Imidazotriazinonas 2-fenil substituidas enquanto inibidores de fosfodiesterase
DE69820906D1 (de) Hydroxamsäure-derivate als matrix metalloproteinaseinhibitoren
DE69720051D1 (de) Harnstoffderivate
DE69716615D1 (de) Heterozyklische metalloproteaseinhibitoren
DE69817186D1 (de) Diaminorhodamin-derivate
DK0958287T3 (da) Sulfamidmetalloprotease-inhibitorer
ATE353326T1 (de) Piperazin-derivate
DE69817671D1 (de) Antragsrolle
ATE255098T1 (de) Substituierte chromanderivate
DE69728139D1 (de) Pyrrolopyrrolone als inhibitoren von neutrophiler elastase
DE69841086D1 (de) 5-Deoxy-Cytidin-Derivate
DE69806750D1 (de) Amidinderivate als inhibitoren von no-synthase
ATE292632T1 (de) Cis-disubstituierte aminocycloalkyl-pyrrolidin- derivate
DE69828780D1 (de) Amidinocamptpthecin-derivate
NO981495L (no) Fenoksymetylpiperidin-derivater
DK0966437T3 (da) 5-Aroylnaphthalenderivater

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee